Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly listed in the year 1995. Panacea Biotec is a research based Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals, Vaccines and Biosimilars.
Financial Results:
Panacea Biotec Ltd reported Revenues for Q1FY24 of ₹129.00 Crores up from ₹111.00 Crore year on year, a rise of 16.22%.
Total Expenses for Q1FY24 of ₹150.00 Crores down from ₹202.00 Crores year on year, a fall of 25.74%.
Consolidated Net Profit of ₹11.00 Crores from -₹56.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.79, from -₹9.16 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.